Other
Spironolactone
0
Pipeline Programs↗
4
Active Trials↗
5
Companies Involved↗
Spironolactone is an early-stage landscape with 0 programs across 5 companies. The most active players are Sarfez Pharmaceuticals, Inc., Pfizer, AstraZeneca.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
No pipeline programs currently tracked for this disease.
Analysis
Trial Status
35
clinical trials
Completed18 · 51%
Unknown status6 · 17%
Terminated4 · 11%
Withdrawn2 · 6%
Not yet recruiting2 · 6%
Enrolling by invitation1 · 3%
Other2 · 6%
Clinical Trials
Trial Activity
35 trials
Topical 5% Spironolactone Gel Versus 0.1% Adapalene Gel for Acne Vulgaris: A Randomized Split-Face Study
Not yet recruiting·—·Phase 2·NCT07473895·40 enrolled
Page 1 of 3
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)